1 option
Parallel imports of pharmaceutical products in the European Union / Mattias Ganslandt and Keith E. Maskus.
World Bank Open Knowledge Repository (formerly "World Bank E-Library Publications") Available online
View online- Format:
- Book
- Government document
- Author/Creator:
- Ganslandt, Mattias.
- Series:
- Policy research working papers ; 2629.
- World Bank e-Library.
- Policy research working paper ; 2630
- Language:
- English
- Subjects (All):
- Drugs--Prices--European Union countries--Econometric models.
- Drugs.
- Gray market--European Union countries--Econometric models.
- Gray market.
- Imports--European Union countries--Econometric models.
- Imports.
- Price regulation--European Union countries--Econometric models.
- Price regulation.
- Trademarks (International law)--Econometric models.
- Trademarks (International law).
- Other Title:
- Policy research working paper vol. 2630
- Place of Publication:
- Washington, D.C. : World Bank, Development Research Group, Trade, 2001.
- System Details:
- data file
- Summary:
- Parallel imports are legitimately produced goods imported legally into a country without the authorization of a trademark, copyright, or patent holder. In the European Union, so long as a pharmaceutical manufacturer has placed a good on the market voluntarily, the principle of free movement of goods allows individuals or firms within the EU to trade goods across borders without the consent of the producer. What is the effect of these parallel imports?
- Notes:
- "July 2001."
- Title from title screen as viewed on Sept. 07, 2002.
- Includes bibliographical references (p. 22).
- Publisher Number:
- 10.1596/1813-9450-2630
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.